A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Evogliptin Impurity 4 - Request Quote

Picture of Evogliptin Impurity 4

Evogliptin Impurity 4

SZ CAT No:SZ-E047010
CAS No
NA
Mol.F.
C19H27F2N3O3 : C4H6O6
Mol.Wt.
383.4 : 150.1
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Evogliptin Impurity 4 is chemically (3R)-4-(3-Amino-4-(2,5-difluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one (2R,3R)-2,3-dihydroxysuccinate. Evogliptin Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Evogliptin Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Evogliptin Tartrate.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Evogliptin Impurity 4

Purchase Evogliptin Impurity 4

Evogliptin Impurity 4 suppliers

Evogliptin Impurity 4 manufacturers

Evogliptin Impurity 4 price

Order Evogliptin Impurity 4

Enquire Evogliptin Impurity 4

Evogliptin Impurity 4 cost

Evogliptin Impurity 4 Supplier

Evogliptin Impurity 4 Distributor

Evogliptin Impurity 4 for Method Validation

Evogliptin Tartrate Reference Standard

Evogliptin Impurity 4 for ANDA Filing

Evogliptin Impurity 4 for Forced Degradation Studies

Evogliptin Impurity 4 Identification Standards

Evogliptin Impurity 4 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,